Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2016, Article ID 2613401, 7 pages
http://dx.doi.org/10.1155/2016/2613401
Review Article

Chaperone-Mediated Autophagy and Mitochondrial Homeostasis in Parkinson’s Disease

1Department of Neurosurgery, Tangdu Hospital, The Fourth Military Medical University, 569 Xinsi Road, Xi’an, Shaanxi 710038, China
2Department of Pharmacology and Neurology, School of Medicine, Emory University, Atlanta, GA 30322, USA

Received 27 December 2015; Revised 4 April 2016; Accepted 29 May 2016

Academic Editor: Matthew Gegg

Copyright © 2016 Ruixin Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. M. de Lau and M. M. Breteler, “Epidemiology of Parkinson's disease,” Lancet Neurology, vol. 5, no. 6, pp. 525–535, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. A. E. Lang and A. M. Lozano, “Parkinson's disease. First of two parts,” The New England Journal of Medicine, vol. 339, no. 15, pp. 1044–1053, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. A. E. Lang and A. M. Lozano, “Parkinson's disease: second of two parts,” The New England Journal of Medicine, vol. 339, no. 16, pp. 1130–1143, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. M. G. Spillantini, R. A. Crowther, R. Jakes, M. Hasegawa, and M. Goedert, “α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 11, pp. 6469–6473, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Spatola and C. Wider, “Genetics of Parkinson's disease: the yield,” Parkinsonism and Related Disorders, vol. 20, supplement 1, pp. S35–S38, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Vilchez, I. Saez, and A. Dillin, “The role of protein clearance mechanisms in organismal ageing and age-related diseases,” Nature Communications, vol. 5, article 5659, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. J. C. Corona and M. R. Duchen, “Impaired mitochondrial homeostasis and neurodegeneration: towards new therapeutic targets?” Journal of Bioenergetics and Biomembranes, vol. 47, no. 1-2, pp. 89–99, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Y. Han, J. S. Kim, and J. H. Son, “Mitochondrial homeostasis molecules: regulation by a trio of recessive Parkinson's disease genes,” Experimental Neurobiology, vol. 23, no. 4, pp. 345–351, 2014. View at Publisher · View at Google Scholar
  9. A. M. Pickrell and R. J. Youle, “The roles of PINK1, parkin, and mitochondrial fidelity in parkinson's disease,” Neuron, vol. 85, no. 2, pp. 257–273, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Sai, Z. Zou, K. Peng, and Z. Dong, “The Parkinson's disease-related genes act in mitochondrial homeostasis,” Neuroscience and Biobehavioral Reviews, vol. 36, no. 9, pp. 2034–2043, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. P. K. Kamat, A. Kalani, P. Kyles, S. C. Tyagi, and N. Tyagi, “Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease,” Cell Biochemistry and Biophysics, vol. 70, no. 2, pp. 707–719, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. C. Wong and E. L. F. Holzbaur, “Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 42, pp. E4439–E4448, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Mizushima, B. Levine, A. M. Cuervo, and D. J. Klionsky, “Autophagy fights disease through cellular self-digestion,” Nature, vol. 451, no. 7182, pp. 1069–1075, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. D. J. Klionsky, “The molecular machinery of autophagy: unanswered questions,” Journal of Cell Science, vol. 118, no. 1, pp. 7–18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. A. C. Massey, C. Zhang, and A. M. Cuervo, “Chaperone-mediated autophagy in aging and disease,” Current Topics in Developmental Biology, vol. 73, pp. 205–235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Schiavi and N. Ventura, “The interplay between mitochondria and autophagy and its role in the aging process,” Experimental Gerontology, vol. 56, pp. 147–153, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Lionaki, M. Markaki, K. Palikaras, and N. Tavernarakis, “Mitochondria, autophagy and age-associated neurodegenerative diseases: new insights into a complex interplay,” Biochimica et Biophysica Acta—Bioenergetics, vol. 1847, no. 11, pp. 1412–1423, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Xie, L. Zhang, H. Jiao et al., “Chaperone-mediated autophagy prevents apoptosis by degrading BBC3/PUMA,” Autophagy, vol. 11, no. 9, pp. 1623–1635, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. A. S. Rambold and J. Lippincott-Schwartz, “Mechanisms of mitochondria and autophagy crosstalk,” Cell Cycle, vol. 10, no. 23, pp. 4032–4038, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Wei, L. Liu, and Q. Chen, “Selective removal of mitochondria via mitophagy: distinct pathways for different mitochondrial stresses,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1853, no. 10, pp. 2784–2790, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Hara, K. Nakamura, M. Matsui et al., “Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice,” Nature, vol. 441, no. 7095, pp. 885–889, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Mariño, F. Madeo, and G. Kroemer, “Autophagy for tissue homeostasis and neuroprotection,” Current Opinion in Cell Biology, vol. 23, no. 2, pp. 198–206, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. H. Son, J. H. Shim, K.-H. Kim, J.-Y. Ha, and J. Y. Han, “Neuronal autophagy and neurodegenerative diseases,” Experimental and Molecular Medicine, vol. 44, no. 2, pp. 89–98, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Liu, S. Huang, X. Wang, B. Tang, W. Li, and Z. Mao, “Chaperone-mediated autophagy and neurodegeneration: connections, mechanisms, and therapeutic implications,” Neuroscience Bulletin, vol. 31, no. 4, pp. 407–415, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. A. M. Cuervo and E. Wong, “Chaperone-mediated autophagy: roles in disease and aging,” Cell Research, vol. 24, no. 1, pp. 92–104, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. E. M. Valente, P. M. Abou-Sleiman, V. Caputo et al., “Hereditary early-onset Parkinson's disease caused by mutations in PINK1,” Science, vol. 304, no. 5674, pp. 1158–1160, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Narendra, A. Tanaka, D.-F. Suen, and R. J. Youle, “Parkin is recruited selectively to impaired mitochondria and promotes their autophagy,” The Journal of Cell Biology, vol. 183, no. 5, pp. 795–803, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Vives-Bauza, C. Zhou, Y. Huang et al., “PINK1-dependent recruitment of Parkin to mitochondria in mitophagy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 1, pp. 378–383, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Shimura, N. Hattori, S.-I. Kubo et al., “Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase,” Nature Genetics, vol. 25, no. 3, pp. 302–305, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. V. A. Hristova, S. A. Beasley, R. J. Rylett, and G. S. Shaw, “Identification of a Novel Zn2+-binding Domain in the Autosomal Recessive Juvenile Parkinson-related E3 Ligase Parkin,” Journal of Biological Chemistry, vol. 284, no. 22, pp. 14978–14986, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Geisler, K. M. Holmström, D. Skujat et al., “PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1,” Nature Cell Biology, vol. 12, no. 2, pp. 119–131, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Matsuda, S. Sato, K. Shiba et al., “PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy,” The Journal of Cell Biology, vol. 189, no. 2, pp. 211–221, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. D. P. Narendra, S. M. Jin, A. Tanaka et al., “PINK1 is selectively stabilized on impaired mitochondria to activate Parkin,” PLoS Biology, vol. 8, no. 1, article e1000298, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Geisler, K. M. Holmström, A. Treis et al., “The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations,” Autophagy, vol. 6, no. 7, pp. 871–878, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. J.-Y. Lee, Y. Nagano, J. P. Taylor, K. L. Lim, and T.-P. Yao, “Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy,” Journal of Cell Biology, vol. 189, no. 4, pp. 671–679, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Zhu, K. Z. Q. Wang, and C. T. Chu, “After the banquet: mitochondrial biogenesis, mitophagy, and cell survival,” Autophagy, vol. 9, no. 11, pp. 1663–1676, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Dupuis, “Mitochondrial quality control in neurodegenerative diseases,” Biochimie, vol. 100, no. 1, pp. 177–183, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. R. L. A. de Vries and S. Przedborski, “Mitophagy and Parkinson's disease: be eaten to stay healthy,” Molecular and Cellular Neuroscience, vol. 55, pp. 37–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Hattori, S. Saiki, and Y. Imai, “Regulation by mitophagy,” International Journal of Biochemistry and Cell Biology, vol. 53, pp. 147–150, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. E. S. Vincow, G. Merrihew, R. E. Thomas et al., “The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 16, pp. 6400–6405, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. G.-L. McLelland, V. Soubannier, C. X. Chen, H. M. McBride, and E. A. Fon, “Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control,” The EMBO Journal, vol. 33, no. 4, pp. 282–295, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. S. A. Sarraf, M. Raman, V. Guarani-Pereira et al., “Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization,” Nature, vol. 496, no. 7445, pp. 372–376, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. A. M. Cuervo, “Chaperone-mediated autophagy: selectivity pays off,” Trends in Endocrinology and Metabolism, vol. 21, no. 3, pp. 142–150, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. J. F. Dice, “Chaperone-mediated autophagy,” Autophagy, vol. 3, no. 4, pp. 295–299, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. J. F. Dice, “Peptide sequences that target cytosolic proteins for lysosomal proteolysis,” Trends in Biochemical Sciences, vol. 15, no. 8, pp. 305–309, 1990. View at Publisher · View at Google Scholar · View at Scopus
  46. W. Li, Q. Yang, and Z. Mao, “Chaperone-mediated autophagy: machinery, regulation and biological consequences,” Cellular and Molecular Life Sciences, vol. 68, no. 5, pp. 749–763, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. L. M. Thompson, C. T. Aiken, L. S. Kaltenbach et al., “IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome,” The Journal of Cell Biology, vol. 187, no. 7, pp. 1083–1099, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Quintavalle, S. Di Costanzo, C. Zanca et al., “Phosphorylation-regulated degradation of the tumor-suppressor form of PED by chaperone-mediated autophagy in lung cancer cells,” Journal of Cellular Physiology, vol. 229, no. 10, pp. 1359–1368, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. A. E. Majeski and J. F. Dice, “Mechanisms of chaperone-mediated autophagy,” International Journal of Biochemistry and Cell Biology, vol. 36, no. 12, pp. 2435–2444, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. Z. Cai, W. Zeng, K. Tao, E. Zhen, B. Wang, and Q. Yang, “Chaperone-mediated autophagy: roles in neuroprotection,” Neuroscience Bulletin, vol. 31, no. 4, pp. 452–458, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. A. M. Cuervo and J. F. Dice, “A receptor for the selective uptake and degradation of proteins by lysosomes,” Science, vol. 273, no. 5274, pp. 501–503, 1996. View at Publisher · View at Google Scholar · View at Scopus
  52. U. Bandyopadhyay, S. Kaushik, L. Varticovski, and A. M. Cuervo, “The chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane,” Molecular and Cellular Biology, vol. 28, no. 18, pp. 5747–5763, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. N. Salvador, C. Aguado, M. Horst, and E. Knecht, “Import of a cytosolic protein into lysosomes by chaperone-mediated autophagy depends on its folding state,” The Journal of Biological Chemistry, vol. 275, no. 35, pp. 27447–27456, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. F. A. Agarraberes and J. F. Dice, “A molecular chaperone complex at the lysosomal membrane is required for protein translocation,” Journal of Cell Science, vol. 114, no. 13, pp. 2491–2499, 2001. View at Google Scholar · View at Scopus
  55. S. Kaushik and A. M. Cuervo, “Chaperone-mediated autophagy: a unique way to enter the lysosome world,” Trends in Cell Biology, vol. 22, no. 8, pp. 407–417, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. R. Kiffin, C. Christian, E. Knecht, and A. M. Cuervo, “Activation of chaperone-mediated autophagy during oxidative stress,” Molecular Biology of the Cell, vol. 15, no. 11, pp. 4829–4840, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. A. C. Massey, S. Kaushik, G. Sovak, R. Kiffin, and A. M. Cuervo, “Consequences of the selective blockage of chaperone-mediated autophagy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 15, pp. 5805–5810, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. A. M. Cuervo, E. Knecht, S. R. Terlecky, and J. F. Dice, “Activation of a selective pathway of lysosomal proteolysis in rat liver by prolonged starvation,” American Journal of Physiology—Cell Physiology, vol. 269, no. 5, part 1, pp. C1200–C1208, 1995. View at Google Scholar · View at Scopus
  59. E. Dohi, S. Tanaka, T. Seki et al., “Hypoxic stress activates chaperone-mediated autophagy and modulates neuronal cell survival,” Neurochemistry International, vol. 60, no. 4, pp. 431–442, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. L. Alvarez-Erviti, M. C. Rodriguez-Oroz, J. M. Cooper et al., “Chaperone-mediated autophagy markers in Parkinson disease brains,” Archives of Neurology, vol. 67, no. 12, pp. 1464–1472, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. K. E. Murphy, A. M. Gysbers, S. K. Abbott et al., “Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease,” Movement Disorders, vol. 30, no. 12, pp. 1639–1647, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. A. M. Cuervo, L. Stafanis, R. Fredenburg, P. T. Lansbury, and D. Sulzer, “Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy,” Science, vol. 305, no. 5688, pp. 1292–1295, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. S. J. Orenstein, S.-H. Kuo, I. Tasset et al., “Interplay of LRRK2 with chaperone-mediated autophagy,” Nature Neuroscience, vol. 16, no. 4, pp. 394–406, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. T. Vogiatzi, M. Xilouri, K. Vekrellis, and L. Stefanis, “Wild type α-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells,” Journal of Biological Chemistry, vol. 283, no. 35, pp. 23542–23556, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. T.-F. Jiang and S.-D. Chen, “Dysfunction of two lysosome degradation pathways of α-synuclein in Parkinson's disease: potential therapeutic targets?” Neuroscience Bulletin, vol. 28, no. 5, pp. 649–657, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Xilouri, O. R. Brekk, and L. Stefanis, “α-Synuclein and protein degradation systems: a reciprocal relationship,” Molecular neurobiology, vol. 47, no. 2, pp. 537–551, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. T. Kabuta, A. Furuta, S. Aoki, K. Furuta, and K. Wada, “Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy,” Journal of Biological Chemistry, vol. 283, no. 35, pp. 23731–23738, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. T. Kabuta and K. Wada, “Insights into links between familial and sporadic Parkinson's disease: physical relationship between UCH-L1 variants and chaperone-mediated autophagy,” Autophagy, vol. 4, no. 6, pp. 827–829, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. Y.-T. Yu, R. E. Breitbart, L. B. Smoot, Y. Lee, V. Mahdavi, and B. Nadal-Ginard, “Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors,” Genes and Development, vol. 6, no. 9, pp. 1783–1798, 1992. View at Publisher · View at Google Scholar · View at Scopus
  70. Z. Mao and X. Wang, “Expression, function, and regulation of transcription factor MEF2 in neurons,” in Transcription Factors in the Nervous System, G. Thiel, Ed., chapter 14, pp. 285–305, Wiley-Blackwell, 2006. View at Google Scholar
  71. K. A. Heidenreich and D. A. Linseman, “Myocyte enhancer factor-2 transcription factors in neuronal differentiation and survival,” Molecular Neurobiology, vol. 29, no. 2, pp. 155–165, 2004. View at Publisher · View at Google Scholar · View at Scopus
  72. Z. Mao, A. Bonni, F. Xia, M. Nadal-Vicens, and M. E. Greenberg, “Neuronal activity-dependent cell survival mediated by transcription factor MEF2,” Science, vol. 286, no. 5440, pp. 785–790, 1999. View at Publisher · View at Google Scholar · View at Scopus
  73. X. Gong, X. Tang, M. Wiedmann et al., “Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis,” Neuron, vol. 38, no. 1, pp. 33–46, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. X. Tang, X. Wang, X. Gong et al., “Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor 2,” Journal of Neuroscience, vol. 25, no. 19, pp. 4823–4834, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. P. D. Smith, S. J. Crocker, V. Jackson-Lewis et al., “Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 23, pp. 13650–13655, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. P. D. Smith, M. P. Mount, R. Shree et al., “Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2,” Journal of Neuroscience, vol. 26, no. 2, pp. 440–447, 2006. View at Publisher · View at Google Scholar · View at Scopus
  77. Q. Yang and Z. Mao, “Dysregulation of autophagy and Parkinson's disease: the MEF2D link,” Apoptosis, vol. 15, no. 11, pp. 1410–1414, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. Q. Yang, H. She, M. Gearing et al., “Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy,” Science, vol. 323, no. 5910, pp. 124–127, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. L. Gao, H. She, W. Li et al., “Oxidation of survival factor MEF2D in neuronal death and Parkinson's disease,” Antioxidants and Redox Signaling, vol. 20, no. 18, pp. 2936–2948, 2014. View at Publisher · View at Google Scholar · View at Scopus
  80. E. C. Stack, J. L. Ferro, J. Kim et al., “Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease,” Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, vol. 1782, no. 3, pp. 151–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Mehta, M. Prabhakar, P. Kumar, R. Deshmukh, and P. L. Sharma, “Excitotoxicity: bridge to various triggers in neurodegenerative disorders,” European Journal of Pharmacology, vol. 698, no. 1–3, pp. 6–18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. E. Deas, N. Cremades, P. R. Angelova et al., “Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson's disease,” Antioxidants & Redox Signaling, vol. 24, no. 7, pp. 376–391, 2016. View at Publisher · View at Google Scholar
  83. S. R. Subramaniam and M.-F. Chesselet, “Mitochondrial dysfunction and oxidative stress in Parkinson's disease,” Progress in Neurobiology, vol. 106-107, pp. 17–32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  84. V. Dias, E. Junn, and M. M. Mouradian, “The role of oxidative stress in Parkinson's disease,” Journal of Parkinson's Disease, vol. 3, no. 4, pp. 461–491, 2013. View at Publisher · View at Google Scholar · View at Scopus
  85. J. Blesa, I. Trigo-Damas, A. Quiroga-Varela, and V. R. Jackson-Lewis, “Oxidative stress and Parkinson’s disease,” Frontiers in Neuroanatomy, vol. 9, article 91, 2015. View at Publisher · View at Google Scholar · View at Scopus
  86. F. J. Naya, B. L. Black, H. Wu et al., “Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor,” Nature Medicine, vol. 8, no. 11, pp. 1303–1309, 2002. View at Publisher · View at Google Scholar · View at Scopus
  87. H. She, Q. Yang, K. Shepherd et al., “Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients,” Journal of Clinical Investigation, vol. 121, no. 3, pp. 930–940, 2011. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Anderson, A. T. Bankier, B. G. Barrell et al., “Sequence and organization of the human mitochondrial genome,” Nature, vol. 290, no. 5806, pp. 457–465, 1981. View at Publisher · View at Google Scholar · View at Scopus
  89. Y. Bai and G. Attardi, “The mtDNA-encoded ND6 subunit of mitochondrial NADH dehydrogenase is essential for the assembly of the membrane arm and the respiratory function of the enzyme,” EMBO Journal, vol. 17, no. 16, pp. 4848–4858, 1998. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Falkenberg, N.-G. Larsson, and C. M. Gustafsson, “DNA replication and transcription in mammalian mitochondria,” Annual Review of Biochemistry, vol. 76, pp. 679–699, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. S. Kösel, E. M. Grasbon-Frodl, U. Mautsch et al., “Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease,” Neurogenetics, vol. 1, no. 3, pp. 197–204, 1998. View at Publisher · View at Google Scholar · View at Scopus
  92. P. M. Keeney, J. Xie, R. A. Capaldi, and J. P. Bennett Jr., “Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled,” Journal of Neuroscience, vol. 26, no. 19, pp. 5256–5264, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. A. H. V. Schapira, J. M. Cooper, D. Dexter, P. Jenner, J. B. Clark, and C. D. Marsden, “Mitochondrial complex I deficiency in Parkinson's disease,” The Lancet, vol. 333, no. 8649, p. 1269, 1989. View at Publisher · View at Google Scholar · View at Scopus
  94. A. H. V. Schapira, J. M. Cooper, D. Dexter, J. B. Clark, P. Jenner, and C. D. Marsden, “Mitochondrial complex I deficiency in Parkinson's disease,” Journal of Neurochemistry, vol. 54, no. 3, pp. 823–827, 1990. View at Publisher · View at Google Scholar · View at Scopus
  95. M. K. McCoy and M. R. Cookson, “DJ-1 regulation of mitochondrial function and autophagy through oxidative stress,” Autophagy, vol. 7, no. 5, pp. 531–532, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. V. Bonifati, P. Rizzu, M. J. van Baren et al., “Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism,” Science, vol. 299, no. 5604, pp. 256–259, 2003. View at Publisher · View at Google Scholar · View at Scopus
  97. B. Wang, Z. Cai, K. Tao et al., “Essential control of mitochondrial morphology and function by chaperone-mediated autophagy through degradation of PARK7,” Autophagy, 2016. View at Publisher · View at Google Scholar